Faculty profile

Gerard Morton

Back to faculty

Professor Emeritus/EmeritaDepartment of Radiation OncologyUniversity of Toronto

Gerard Morton

Professor Emeritus/Emerita

Department of Radiation Oncology

Temerty Faculty of Medicine

University of Toronto

Toronto, Ontario, Canada

ORCID

Supervision signals

Emeritus professors are retired and rarely take new students.
29 publications in the last five years, latest in 2027.
Senior (last) author on 3 recent papers, a sign of leading a research group.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

473

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Education

MB, BCh BAO

Profiles and links

University Profile Search on Google Scholar iDORCID

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their University of Toronto profile.

Clinical oncology Cancer

Latest papers

Prostate and pelvic SABR with or without a focal boost: results from a multicenter phase II prospective clinical trial.
Clinical and translational radiation oncology · 2027
Bowel Bag Dosimetric Parameters for Ultrahypofractionated Pelvic Elective Nodal Irradiation in Prostate Cancer.
International journal of radiation oncology, biology, physics · 2026
Innovative and Customized 3-Dimensional-Printed Mold Brachytherapy Treatment of Genital Extramammary Paget's Disease.
Advances in radiation oncology · 2026

All 96 publications

Latest funding

Androgen Suppression Combined with Elective Nodal and a Dose Escalated Boost. A Non-Inferiority, Phase 3 Randomized Controlled Trial of Stereotactic Body Radiation Therapy versus Brachytherapy Boost (ASCENDE-SBRT)
CIHR · 2022 · Co-investigator
$4,475,254
High dose rate endorectal brachytherapy for patients with operable rectal cancer
CIHR · 2009 · Co-investigator
$100,000

All 2 grants and awards

96 publications.

Prostate and pelvic SABR with or without a focal boost: results from a multicenter phase II prospective clinical trial.

Alayed Y, Gopaul D, Mendez LC, Kwan W, Liu SK, Chu W, Tseng CL, Cheung P, Vesprini D, Chung H, Morton G, Correa R, Musunuru B, Davidson M, Ravi A, Deabreu A, Mamedov A, Poon E, Zhang L, Loblaw A

Clinical and translational radiation oncology2027

DOI: 10.1016/j.ctro.2026.101256 PMID: 42750816

Bowel Bag Dosimetric Parameters for Ultrahypofractionated Pelvic Elective Nodal Irradiation in Prostate Cancer.

Ong WL, Davidson M, Wronski M, Kang T, Cheung P, Chu W, Chung H, Liu S, Morton G, Tseng CL, Vesprini D, Zhang L, Poon C, Loblaw A

International journal of radiation oncology, biology, physics2026

DOI: 10.1016/j.ijrobp.2025.08.014 PMID: 40819809

Innovative and Customized 3-Dimensional-Printed Mold Brachytherapy Treatment of Genital Extramammary Paget's Disease.

Pacora RDC, Paudel MR, Smith M, Morton G, Barnes E, Kazem M, Sidiropoulos M, Taggar AS

Advances in radiation oncology2026

DOI: 10.1016/j.adro.2025.101969 PMID: 41550121

Development and pilot evaluation of a virtual reality simulator for HDR prostate brachytherapy.

Varlukhin A, Smith M, Alam F, Tagger A, Morton G, Paudel M, Loblaw A, Mendez LC, Hoover D, Karshafian R, Nusrat H

Brachytherapy2026

DOI: 10.1016/j.brachy.2026.05.006 PMID: 42498540

SBRT vs HDR Brachytherapy for Intermediate-Risk Prostate Cancer.

Udovicich C, Cheung P, Chu W, Chung H, Detsky J, Liu S, Morton G, Tseng CL, Vesprini D, Hudson JM, Ong WL, Kennedy T, Helou J, Davidson M, Ravi A, McGuffin M, Zhang L, Mamedov A, Deabreu A, Kulasingham-Poon M, Loblaw A

JAMA network open2026

DOI: 10.1001/jamanetworkopen.2026.0146 PMID: 41739470

Core competencies in prostate HDR brachytherapy: An American Brachytherapy Society Endorsed Competency Framework.

Taggar AS, Poder J, Goel A, Shiao JC, Hu HP, Chang AJ, Kollmeier MA, Morton G

Brachytherapy2026Senior author

DOI: 10.1016/j.brachy.2026.04.008 PMID: 42156316

Two-fraction Versus Five-fraction Stereotactic Body Radiotherapy for Intermediate-risk Prostate Cancer: The TOFFEE Meta-analysis of Individual Patient Data from Four Prospective Trials.

Udovicich C, Cheung P, Chu W, Chung H, Detsky J, Liu S, Morton G, Szumacher E, Tseng CL, Vesprini D, Ong WL, Kennedy T, Davidson M, Ravi A, McGuffin M, Zhang L, Mamedov A, Deabreu A, Kulasingham-Poon M, Loblaw A

European urology oncology2025

DOI: 10.1016/j.euo.2024.12.015 PMID: 39904690

Updated results of MR-assisted focal salvage HDR prostate brachytherapy: a prospective study.

Paulin G, Morton G, Loblaw A, Tseng CL, Corkum M, Murgic J, Ravi A, Davidson M, Wronski M, Paudel M, Haider M, Deabreu A, Zhang L, Chung HT

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology2025

DOI: 10.1016/j.radonc.2025.111091 PMID: 40789422

High-dose-rate (HDR) brachytherapy boost in combination with external beam radiotherapy for localized prostate cancer: An evidence-based consensus statement.

Patel SA, Kollmeier M, Crook J, Krauss D, Morton G, Chang AJ, Helou J, Hsu IC, Menard C, Patel S, Robin T, Rossi PJ, Zelefsky MJ, Kamrava MR

Brachytherapy2025

DOI: 10.1016/j.brachy.2025.06.005 PMID: 40707306

Joint ABS/GEC-ESTRO Consensus Statement on the objectives of training in brachytherapy for physicians.

Keyes M, Sturdza AE, Crook J, Anderson B, Boldrini L, Chino J, Corradini S, Deufel C, Farach A, Folkert MR, Frank SJ, Hannoun-Levi JM, Hoskin P, Jurgenliemk-Schulz I, Kamrava M, Kollmeier M, McKee MM, Iii POF, Rossi P, Pieters BR, Strnad V, Shah C, Siebert FA, Stewart A, Taggar AS, Tagliaferri L, Morton G

Brachytherapy2025Senior author

DOI: 10.1016/j.brachy.2025.05.006 PMID: 40610289

Profile data last refreshed on September 25, 2026 from the university directory, publication records and CIHR, NSERC and SSHRC funding.

Something wrong or missing on this profile? Suggest a correction

Gerard Morton

Research

Latest papers

Latest funding

Prostate and pelvic SABR with or without a focal boost: results from a multicenter phase II prospective clinical trial.

Bowel Bag Dosimetric Parameters for Ultrahypofractionated Pelvic Elective Nodal Irradiation in Prostate Cancer.

Innovative and Customized 3-Dimensional-Printed Mold Brachytherapy Treatment of Genital Extramammary Paget's Disease.

Development and pilot evaluation of a virtual reality simulator for HDR prostate brachytherapy.

SBRT vs HDR Brachytherapy for Intermediate-Risk Prostate Cancer.

Core competencies in prostate HDR brachytherapy: An American Brachytherapy Society Endorsed Competency Framework.

Two-fraction Versus Five-fraction Stereotactic Body Radiotherapy for Intermediate-risk Prostate Cancer: The TOFFEE Meta-analysis of Individual Patient Data from Four Prospective Trials.

Updated results of MR-assisted focal salvage HDR prostate brachytherapy: a prospective study.

High-dose-rate (HDR) brachytherapy boost in combination with external beam radiotherapy for localized prostate cancer: An evidence-based consensus statement.

Joint ABS/GEC-ESTRO Consensus Statement on the objectives of training in brachytherapy for physicians.

Androgen Suppression Combined with Elective Nodal and a Dose Escalated Boost. A Non-Inferiority, Phase 3 Randomized Controlled Trial of Stereotactic Body Radiation Therapy versus Brachytherapy Boost (ASCENDE-SBRT)

High dose rate endorectal brachytherapy for patients with operable rectal cancer

Frequent collaborators

Andrew Loblaw

Ewa Szumacher

Stanley Liu

Mira Keyes

Eric Vigneault

Glenn Bauman

Katherine Zukotynski

Scott Tyldesley

Michael Mckenzie

Sender Herschorn

Colm Boylan

Michael Milosevic

Gregory Pond

Alejandro Berlin

Nicole Mittmann

Katherine Zukotynski

Fahad Alam

Cynthia Menard

Fei-Fei Liu

George Rodrigues

Alireza Sadeghian